Notifications
Clear all
Topic starter
01/06/2026 6:01 am
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows.
https://themedicinemaker.com/issues/2026/articles/june/the-new-reality-of-peptide-analysis/